Results 31 to 40 of about 34,419 (264)
Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi +19 more
wiley +1 more source
CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao +7 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal state for Lewy body disorders and exhibits biological heterogeneity that may influence clinical expression and progression. We examined clinical features in individuals with iRBD and biomarker‐defined synucleinopathy.
Daniel Weintraub +24 more
wiley +1 more source
Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito +8 more
wiley +1 more source
Consumer perception of private label brands in the Czech Republic
Littera Scripta, 2011 The very tough fight for customers in the retail trade is reflected by the strong growth in the number of products sold under private labels that are currently becoming an important factor in business competitiveness.
Věra Mulačová, Petr Mulač
doaj
Ouverture de 'Over-Supply and Global Markets – 2'
Symphonya, 2005 Globalisation and over-supplied markets impose new behaviour to achieve stable performance, with corporate strategies based on: downsizing, networking, merging, development of intangibles.
Silvio M. Brondoni
doaj +1 more source
Arthritis Care &Research, EarlyView.Objective Rheumatic and musculoskeletal diseases (RMDs) are leading causes of physical disability, necessitating support with activities of daily living. This study describes social care received by patients with RMDs in two disparate regions of England: Salford (urban) and Norfolk (rural).
Mehreen Somro +6 more
wiley +1 more source
Chain store management through private labels strategy
Tržište, 2007 The purpose of this paper is to examine the market shares of private labels in the European Union and on the global market, and to compare the results of the analysis with the level of presence of private labels on the Croatian market.
Martina Sopta
doaj
Private Label and Macroeconomic Indicators: Europe and USA
Administrative Sciences, 2020 In this study, we have analyzed the impact and evolution of some of the most important macroeconomic indices on the market share and value of private brands. The originality and objective of this work is the linkage of macroeconomic variables in European
Eloy Gil-Cordero +2 more
doaj +1 more source
Fairtrade products in retail chains: Case study in the Czech Republic
Entrepreneurship and Sustainability Issues, 2023 The main objective of the article was to find out what the situation is with Fairtrade products on the Czech and Slovak markets in relation to consumed primary raw materials and their Fairtrade epremium, and also the supply of these products in retail ...
Alena Srbová, Nikola Sagapova
doaj +1 more source